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Comparison of semiautomated tangential VMAT with 3DCRT for breast or chest
wall and regional nodes
Abstract
Radiotherapy to the breast after surgery sometimes requires adjoining nodes to be included in the
treatment volume. In these cases, the traditional approach has been a complex 3-Dimensional Conformal
Radiotherapy (3DCRT) beam arrangement which can result in significant dose heterogeneity at the beam
junctions. A Volumetric Modulated Arc Therapy (VMAT) beam arrangement has previously been proposed
for breast cases, where the chest wall/breast is treated with a limited angle (partial arc) tangential VMAT
technique (Viren et al. [2015] Radiat Oncol. 10:79). In our study, this approach is extended to breast and
chest wall cases with adjoining nodes by adding a separate conventional VMAT arc field specifically
limited to the superior nodes. This VMAT method was implemented using a semiautomated approach on
27 patients, and the resultant plan compared to a monoisocentric 3DCRT plan. Plan statistics, DoseVolume Histogram (DVH) analysis and Radiation Oncologist (RO) preference were assessed. When
compared to the 3DCRT technique, the VMAT planning method was found to result in better target volume
coverage, high doses to organs at risk (OAR) were reduced but greater OAR volumes received low doses.
Having said that, the volume receiving low doses with this tangential VMAT technique was less than that
of other VMAT planning methods described in the literature, and the integral dose was less than the
3DCRT method. The VMAT technique also resulted in more robust junction doses that the 3DCRT method.
RO review found that the VMAT technique was preferred in 81% of cases. Specifically, the VMAT plans
were preferred in all categories of patients except left chest wall cases where the intermammary nodes
were also treated. The VMAT technique described here is a useful addition to the treatment options
available for breast/chest wall and nodal patients.
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Mikel Byrne1 | Ben Archibald-Heeren1,2 | Yunfei Hu2,3 | Andrew Fong1 | Leena Chong1 |
Amy Teh1,2,4
1
Radiation Oncology Centres, Sydney
Adventist Hospital, Wahroonga, NSW,
Australia

Abstract
Radiotherapy to the breast after surgery sometimes requires adjoining nodes to be
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included in the treatment volume. In these cases, the traditional approach has been
a complex 3‐Dimensional Conformal Radiotherapy (3DCRT) beam arrangement
which can result in signiﬁcant dose heterogeneity at the beam junctions. A Volumetric Modulated Arc Therapy (VMAT) beam arrangement has previously been proposed for breast cases, where the chest wall/breast is treated with a limited angle
(partial arc) tangential VMAT technique (Virén et al. [2015] Radiat Oncol. 10:79). In
our study, this approach is extended to breast and chest wall cases with adjoining
nodes by adding a separate conventional VMAT arc ﬁeld speciﬁcally limited to the
superior nodes. This VMAT method was implemented using a semiautomated
approach on 27 patients, and the resultant plan compared to a monoisocentric
3DCRT plan. Plan statistics, Dose‐Volume Histogram (DVH) analysis and Radiation
Oncologist (RO) preference were assessed. When compared to the 3DCRT technique, the VMAT planning method was found to result in better target volume coverage, high doses to organs at risk (OAR) were reduced but greater OAR volumes
received low doses. Having said that, the volume receiving low doses with this tangential VMAT technique was less than that of other VMAT planning methods
described in the literature, and the integral dose was less than the 3DCRT method.
The VMAT technique also resulted in more robust junction doses that the 3DCRT
method. RO review found that the VMAT technique was preferred in 81% of cases.
Speciﬁcally, the VMAT plans were preferred in all categories of patients except left
chest wall cases where the intermammary nodes were also treated. The VMAT technique described here is a useful addition to the treatment options available for
breast/chest wall and nodal patients.
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1 | INTRODUCTION
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of beams, selection of optimization settings, and optimization. This
allows for faster and more consistent treatment planning.17 This

Radiotherapy to the breast or chest wall is commonly given as an

scripted method can also be combined with manual optimization, tai-

adjuvant treatment after breast cancer surgery. In some cases where

lored to the patient's speciﬁc anatomy to ﬁnish the plan, described

nodal spread is suspected or conﬁrmed, the supraclavicular (SC), axil-

here as a semiautomated planning approach.

lary (AX), and/or the internal mammary (IM) nodes are also treated.

Respiratory motion presents two potential challenges for inverse

In these cases, the traditional standard treatment has been the com-

planned dynamic ﬁelds used in breast radiotherapy18; ensuring cov-

bination of opposed tangential 3‐Dimensional Conformal Radiother-

erage on the patient external edge with motion, and the minimiza-

apy (3DCRT) beams, sometimes with additional subﬁelds at the same

tion of interplay effects. Coverage on the patient external was

gantry angles, junctioned with anterior‐posterior 3DCRT beams to

ensured in this case using the RayStation robust optimization fea-

the AX and SC nodes, and in some cases electrons to the IM nodes.

ture,19 but can equally well be dealt with using virtual bolus.20 Inter-

Variations on this technique exist, but all 3DCRT techniques require

play is generally not considered an issue if the motion is less than

forward planned ﬁeld junctions in the regions between the breast/

1 cm21 and many fractions are used.22 Both of these conditions are

chest wall PTV and the nodal PTVs. Numerous other methods exist

met in conventionally fractioned breast treatments.18,23,24

1,2

where the

This study presents a plan comparison of the semiautomated

MLCs are moved dynamically according to the tissue separation at

combined VMAT technique versus the conventional 3DCRT tech-

each location. Some research3–5 has suggested that inversely opti-

nique on breast and chest wall cases with adjacent nodal volumes.

mized techniques, such as Volumetric Modulated Arc Therapy

Plan statistics and Radiation Oncologist (RO) evaluation of the plans

(VMAT), may improve coverage while reducing organ at risk (OAR)

were used to determine the preferred plan in each case.

to treat these cases including electronic compensation,

doses in this scenario.
However, the research on VMAT breast planning thus far has
found that it results in a larger area of low dose in the patient3,5–10;

2 | METHOD

speciﬁcally contralateral breast, contralateral lung and heart receive
low doses to a volume far greater than would be delivered from

The 30 most recently treated breast or chest wall radiotherapy cases

traditional 3DCRT breast treatments. This low‐dose bath to healthy

that also required regional nodal irradiation from the authors institu-

organs has been associated with increased risk of secondary

tion were selected. Each case was checked to ensure that each trea-

malignancies11,12 and adverse cardiac events.13 A VMAT technique

ted region had a clearly labeled and unique CTV and corresponding

has been proposed that reduces this issue by using tangential VMAT

PTV. After eliminating unsuitable cases, 27 cases remained repre-

4,15

This has been shown

senting a variety of breast/chest wall and nodal regions being irradi-

to reduce the volume of the patient receiving a low dose while

ated. All cases selected had at least one nodal region irradiated, and

maintaining good target coverage. However, the method as described

in most cases numerous nodal regions irradiated. Eight of the

does not allow for treatments to adjacent regional nodes, which are

patients were left‐sided, while 19 were right‐sided. The cohort

likely to beneﬁt most from the use of VMAT, due to their complex

included both patients that had received breast conserving surgery

shapes and proximity to OARs. The authors hereby propose a VMAT

(12) as well as mastectomy (15). None of the patients utilized the

technique for complex breast cases that require regional nodal

deep inspiration breath hold (DIBH) technique during scan or treat-

irradiation that combines tangential VMAT arcs for treatment of

ment. These cases had previously been treated using a 3DCRT con-

the breast/chest wall, with a separate conventional VMAT arc that

ventional planning technique and were replanned using the

is speciﬁcally limited to the AX and SC nodes and any junction

tangential VMAT technique in the RayStation v5.0 planning system.

region. This method has the potential to get the greatest beneﬁts

The prescription used in this study was 50 Gy in 25 fractions for all

from VMAT by; (1) utilizing tangential arcs for the breast/chest wall

patients. The linear accelerator used for all plans was a Varian 21iX

PTV thus reducing the low dose region when irradiating the chest,

with millennium MLC.

partial arcs for treatment of the breast only.

(2) using full arc VMAT to maximize coverage and OAR avoidance
when irradiating the AX and SC, and (3) improving dose homo-

2.A | Planning

geneity across the ﬁeld junction. If this method achieves compara-

2.A.1 | 3DCRT Planning

ble low‐dose spill to 3DCRT methods, this would diminish concerns
about the signiﬁcance of low‐dose spill from VMAT relative to

The 3DCRT plans were manually created and planned. Within this

3DCRT in breast cases.9,16 This technique also has the potential

cohort, the gantry and collimator angles were not strictly limited, but

beneﬁt of being quicker to plan compared to the 3DCRT

rather chosen to maximize plan quality for the speciﬁc anatomy of

technique.

the patient. However, they followed a basic formula; the plans were

In the RayStation v5.0 treatment planning system (RaySearch

monoisocentric with open parallel opposed tangential beams for the

Laboratories, Stockholm, Sweden), this tangential VMAT planning

breast/chest wall, in combination with forward planned segments

method can be partially automated through the use of relatively sim-

where required at the same gantry angles designed to maximize cov-

ple scripting. The automation allows the creation of plans, placement

erage and minimize any hotspots within the breast/chest wall PTV.
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These were then junctioned with parallel opposed ﬁelds for the SC
and AX region. Each of the beams was shaped with the MLC. The
plans included both 6 and 18 MV beams, as selected by the treatment planner, although in most cases (25/27) both 6 and 18 MV was
used. In a number of the plans (5), electrons were junctioned with
the photon ﬁelds, usually to cover IM nodes. A number of the plans
also used physical bolus. In cases where bolus was used, the corresponding VMAT plan also used the same bolus. Note that all the
3DCRT plans were previously approved and clinically treated plans.

2.A.2 | VMAT planning
The VMAT planning method utilized the tangential VMAT method
described by Virén et al.1 This beam arrangement was combined
with an approximately 240° arc used to treat the AX and SC PTVs.
A single isocenter was used for all arcs which was positioned in the
geometric center of all the PTVs combined, usually falling close to
the chest wall toward the superior edge of the breast or chest wall
PTV. The tangential arcs were set to the breast/chest wall PTV using
the jaw limits in the “beam optimization settings” in RayStation. Similarly, the AX and SC arc was set to the AX and SC PTVs using the
same settings. To allow for more efﬁcient gantry travel during delivery, the AX/SC arc was split in two at the location of the lateral
breast/chest wall arcs. Where the breast/chest wall PTVs were contiguous with the AX/SC PTVs, an overlapping junction region of 2–
3 cm was allowed, where both sets of arcs were able to treat the
PTV in this region. This allowed for the junction to be handled by
the optimizer in a gradual way such that the plan was robust to
small differential positioning offsets.
The planning and plan evaluation was performed using a semiautomated workﬂow. The semiautomated planning workﬂow added
planning volumes required automatically, then created the plan,
added the isocenter, selected beam and collimator angles, added
objectives and clinical goals. The energy used in each VMAT plan

F I G . 1 . Schematic illustration of an example of the VMAT arc
gantry ranges used for a right breast case. The arcs are separated
longitudinally with the four short arcs (orange) only used to treat the
breast/chest wall and IM PTVs and junction region, while the longer
arcs (yellow) are used for the AX and SC PTVs and junction region.
The nominal tangent angle determined by the script is shown as a
light gray line.
At this point, the planner manually adjusted the maximum jaw
positions allowed, so as to cover the correct volumes, as this cannot
be scripted in RayStation v5.0. A second script was then run that
linked each clinical goal with an optimization objective. The script
then optimized the plan for 50 iterations, checked the clinical goals,
for any goal that was not met, increased the weighting of the
optimization objective linked to the failed goal, then continued the
optimization. This optimization method was described by Archibald‐
Heeren et al.17 This was continued for a total of 300 iterations, after
which the plans were manually reviewed and further optimized if
thought necessary.

was 6 MV. The collimator angles used were designed to minimize
MLC travel, and were consistent for each laterality. The tangential
VMAT beam angles were found by determining the location of both

2.B | Plan evaluation

the medial and posterior extent of the PTV, then ﬁnding the angle

The dose‐volume histogram (DVH) parameters evaluated (Table 1)

between these points to give the nominal tangent angle. The tangential VMAT gantry range was then set;

• For the medial arcs as a 40° range starting 30° inside the nominal

were loosely based on the RTOG 1304 clinical trial25 and used a
prescription of 50 Gy in 25 fractions to the breast/chest wall and
nodal regions.

tangent angle and continuing 10° outside. This offset range was

The plans were blinded and separately reviewed by three ROs.

chosen to minimize the travel of the arc across the patient mid-

Each RO selected the plan that they thought was clinically superior.

line.

During this process, the ROs were told not to assess the accuracy of

• For the lateral arcs as a 50° range starting 20° inside the nominal
tangent angle and continuing 30° outside.

contouring, to remove any contouring differences from the plan
analysis as much as possible. To simplify the process, ROs were not
given access to the patient history, demographics or notes, and

These arc ranges were chosen based on the recommendations of
1

therefore were forced to make some assumptions about the priority

Virén et al., and preliminary testing within the RayStation system.

of treating the nodes relative to sparing healthy tissue. To blind the

The RayStation dual arcs function was used to allow the gantry to

RO to the planning technique, the beam displays were disabled, so

pass each location twice in the breast/chest wall region and provide

that all that was visible to the RO during plan review was the patient

better coverage. See Fig. 1 for an example of the arc ranges.

CT and the two plans’ dose distributions.

BYRNE
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T A B L E 1 The DVH parameters used in the VMAT planning based
on RTOG 1304 clinical trial for different regions of interest (ROI).25
ROI

Plan metric

Acceptable
value

Ideal
value

V90 (V45 Gy)

PTV Breast/Chest wall

D95

PTV Breast/Chest wall

D0.3 cc

The median DVH for selected PTVs and OARs is shown in Fig. 2.
Again, the characteristic differences in the DVH with the planning
methods can be seen; VMAT has improved PTV coverage, lower volumes of OARs receiving high doses, and greater volumes of OARs
receiving low doses.

Target volume coverage and dose homogeneity
PTV Breast/Chest wall

687

>99%

The results of the RO plan reviews were; in 10 cases (37%) the

>90%

>95%

VMAT plan was preferred by all three ROs, in 12 cases (44%) the

<120%

<115%

VMAT plan was preferred by two of three ROs, in ﬁve cases (19%)

>90%

PTV IM

V90 (V45 Gy)

>90%

>99%

the 3DCRT plan was preferred by two of three ROs, and in 0

PTV IM

D95

>90%

>95%

cases the 3DCRT plan was preferred by all three ROs. It can be seen

PTV IM

D0.03 cc

<115%

<110%

PTV AX

V90 (V45 Gy)

>90%

>99%

PTV AX

D95

>90%

>95%

PTV AX

D0.03 cc

<115%

<110%

PTV SC

V90 (V45 Gy)

>90%

>99%

estimated beam‐on time for the 3DCRT plan of 49 s. Using the

PTV SC

D95

>90%

>95%

built‐in RayStation arc duration estimation, the average beam‐on

PTV SC

D0.03 cc

<115%

<110%

time for the VMAT plan was 112 s. With careful ordering of the

External

D0.03 cc

<120%

<110%

VMAT arcs, it is possible to minimize the gantry travel between arcs

that the VMAT plans were preferred over the 3DCRT plans in 81%
of cases.
The average MU for the 3DCRT and VMAT planning methods

Organs at risk dose constraints

were 487 and 728 MU, respectively. Assuming the 3DCRT plan was
delivered at the maximum dose rate of 600 MU/min, this leads to an

to equivalent or less than the 3DCRT plan. This leads to a total time

Lung (Ipsilateral)

V20 Gy

<35%

<15%

from ﬁrst beam‐on to last beam‐off of roughly 1 min longer for the

Lung (Ipsilateral)

V10 Gy

<60%

<50%

VMAT plan as compared to the 3DCRT plan (excluding the 3DCRT

Lung (Ipsilateral)

V5 Gy

<70%

<65%

plans requiring electrons, which are expected to have much longer

Lung (Contralateral)

V5 Gy

<15%

<10%

treatment times due to the electron setup time).

<500 cGy

<400 cGy

Heart

Mean dose

Heart

V25 Gy

<10%

<5%

Heart

V15 Gy

<15%

<10%

Heart

D0.03 cc

<3000 cGy

<2500 cGy

Contralateral breast

D0.03 cc

<1000 cGy

<300 cGy

Contralateral breast

D5

<410 cGy

<300 cGy

Spinal cord

D0.03 cc

<4500 cGy

<4000 cGy

4 | DISCUSSION
From Table 2, it can be seen that VMAT was generally better for
target coverage, however was marginally worse for a number of
OAR metrics. Speciﬁcally, VMAT tended to be better at higher
OAR dose metrics, but worse for the low‐dose OAR metrics. A
range of metrics are used to quantify low‐dose volumes in the literature; in this case, the total volume receiving 5 Gy (V5 Gy) and

3 | RESULTS

integral dose (including PTVs) were compared. It can be seen that
indeed the volume receiving 5 Gy was signiﬁcantly higher with the

The plan analysis and comparison based on dose‐volume factors are

VMAT method as compared to 3DCRT; however, the integral dose

summarized in Table 2. It was found that a number of the plan

using VMAT was signiﬁcantly less than 3DCRT. The average reduc-

parameters were not normally distributed and therefore nonparamet-

tion in integral dose seen with VMAT was 10.8 Gy × L. Additional

ric statistics were used for analysis. The location parameter used is

VMAT imaging requirements are not accounted for in this calcula-

the Hodges‐Lehmann estimator, referred to as the pseudo‐median,

tion; however, this differential would more than compensate for

with 95% conﬁdence intervals calculated using Walsh averages. The

even the worst case imaging dose. The use of the tangential VMAT

Wilcoxon signed rank test was used to determine statistical signiﬁ-

method for the breast/chest wall region has substantially reduced

cance, with the null hypothesis (H0) that there is no difference

the low‐dose volume when compared to other VMAT techniques in

between the planning techniques, and statistical signiﬁcance set at

use.3,5–7,10 A comparison of various low‐dose metrics for different

α = 0.05.

VMAT planning methods is shown in Table 3. To allow comparison

These results show that the VMAT technique had statistically

with the patient cohorts used in the different studies, data from

superior target coverage for the breast/chest wall, AX, and SC PTVs.

the present study are shown for all cases and left cases only. The

The results for the IM PTV were not statistically signiﬁcant, due to

metrics displayed in this table were normally distributed and there-

the relatively small patient numbers (11), and large variation in cov-

fore the average value is reported to better allow comparison with

erage in the cohort. The OAR results were more mixed, generally

other studies. A single sample two‐tailed t test was performed

with VMAT superior at the higher dose metrics and 3DCRT superior

between the data from this study and the best case planning

at the lower dose metrics.

parameter from any one of the other studies with comparable
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3DCRT

ROI

Plan metric

Pseudo‐median
(Hodges‐
Lehmann)

|

T A B L E 2 Target volume coverage and OAR dose metrics achieved for 3DCRT and VMAT planning methods.
VMAT
95%
conﬁdence
interval

Clinical goal

Pseudo‐median
(Hodges‐
Lehmann)

95% conﬁdence
interval

Clinical goal

Superior
technique

Accept or
reject H0

Target volume coverage and dose homogeneity
PTV breast/chest wall

V90 (V45 Gy)

98.1%

(87.5%–99.8%)

Acceptable

99.3%

(97.2%–99.9%)

Ideal

VMAT

Reject

PTV breast/chest wall

D95

93.6%

(77.5%–96.9%)

Acceptable

96.5%

(93.1%–98.6%)

Ideal

VMAT

Reject

PTV breast/chest wall

D0.3 cc

(106.3%–122.9%)

Ideal

(107.3%–111.1%)

Ideal

VMAT

Reject

PTV breast/chest wall

V105 (V52.5 Gy)

11.0%

(1.1%–25.8%)

NA

12.5%

(7.3%–22%)

NA

3DCRT

Accept

PTV IM

V90 (V45 Gy)

92.3%

(51.5%–99.2%)

Acceptable

96.8%

(89.2%–98.3%)

Acceptable

VMAT

Accept

PTV IM

D95

89.3%

(36.3%–93.7%)

Fail

92.8%

PTV IM

D0.03 cc

106.6%

(101.1%–111%)

Ideal

108.3%

PTV AX

V90 (V45 Gy)

98.0%

(94.8%–100%)

Acceptable

PTV AX

D95

94.0%

(89.8%–98.7%)

Acceptable

109.9%

PTV AX

D0.03 cc

PTV SC

V90 (V45 Gy)

107.1%

PTV SC

D95

PTV SC

D0.03 cc

104.8%

External

D0.03 cc

110.3%

108.4%

(84.1%–94.5%)

Acceptable

VMAT

Accept

(107.6%–109.7%)

Ideal

3DCRT

Accept

99.7%

(99.1%–100%)

Ideal

VMAT

Accept

97.5%

(95.8%–99.4%)

Ideal

VMAT

Reject

(107.1%–109.1%)

Ideal

3DCRT

Accept

(98.9%–100%)

Ideal

VMAT

Reject

(104.8%–110.7%)

Ideal

98.3%

(78.4%–100%)

Acceptable

108.0%

93.4%

(55.2%–97.8%)

Acceptable

(95.2%–99.3%)

Ideal

VMAT

Reject

(102.2%–109.8%)

Ideal

107.6%

(106.6%–109.1%)

Ideal

3DCRT

Reject

(106.6%–122.9%)

Acceptable

108.6%

(107.4%–111.9%)

Ideal

VMAT

Reject

(2691.8–6596.9)

NA

5444.7

(3432.8–7483.6)

NA

3DCRT

Reject

(107.7–259.1)

NA

165.8

(97.6–232.4)

NA

VMAT

Reject

99.9%
98.0%

Organs at risk dose constraints
External

V5 Gy (cc)

External

Dintegral (Gy x L)

Lung

V20 Gy

27.2%

(15.7%–42%)

Acceptable

22.3%

(15%–33.9%)

Acceptable

VMAT

Reject

Lung (Ipsilateral)

V10 Gy

35.2%

(20.5%–48.8%)

Ideal

37.4%

(24%–50.2%)

Ideal

3DCRT

Accept

Lung (Ipsilateral)

V5 Gy

46.0%

(28.9%–59.9%)

Ideal

55.5%

(38.9%–67%)

Ideal

3DCRT

Reject

(0%–8.1%)

Ideal

3DCRT

Reject

(90.5–592.0)

Ideal

3DCRT

Reject

(Ipsilateral)

Lung (Contralateral)

V5 Gy

Heart

Mean dose (cGy)

4509.3
176.1

0.0%
100.9

(0%–0.6%)

Ideal

(42.8–401.7)

Ideal

2.0%
192.2

Heart

V25 Gy

0.1%

(0%–4.8%)

Ideal

0.0%

(0%–4.4%)

Ideal

VMAT

Accept

Heart

V15 Gy

0.3%

(0%–7.2%)

Ideal

0.2%

(0%–10.1%)

Ideal

VMAT

Accept

Heart

D0.03 cc (cGy)

1176.4

(375.3–3206.9)

Ideal

Contralateral breast

D0.03 cc (cGy)

872.8

(204.6–4719.6)

Acceptable

D5
D0.03 cc (cGy)

130.4
1339.4

(518.1–2408.2)

Ideal

3DCRT

Accept

848.1

(379.8–1756.7)

Acceptable

VMAT

Accept

(62.2–334.5)

Ideal

309.0

(163.7–515.0)

Acceptable

3DCRT

Reject

(147.4–3872.1)

Ideal

1456.0

(467.6–2570.4)

Ideal

3DCRT

Accept
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F I G . 2 . The median DVH for both
3DCRT and VMAT planning methods
shown for selected regions of interests
with interquartile ranges as dashed lines.

cohort listed in the table, to determine whether the reduction in

In 22/27 cases, the VMAT plan was preferred by the majority of

low‐dose metrics was signiﬁcant. In each case P < 0.001, indicating

ROs, and in 5/27 the 3DCRT plan was preferred. Of the ﬁve patients

there was a signiﬁcant reduction in the low‐dose metrics. This

where the 3DCRT plan was preferred to the VMAT plan by the

signiﬁcant

tangential

majority of ROs, three had very similar anatomy and plan character-

VMAT technique more comparable to 3DCRT in terms of low‐dose

istics not shared with the rest of the cohort. The speciﬁc characteris-

metrics. The typical features of the 3DCRT and tangential VMAT

tics shared by these plans were that the left chest wall and IM

dose distributions are shown in the sagittal view in Fig. 3. A full

nodes were among the volumes being treated, and the heart was

arc VMAT plan with optimization parameters identical to the

adjacent to the treatment area. In each of these cases, the 3DCRT

tangential VMAT plan, and beam arrangement according to the

plan had an electron ﬁeld that covered the medial chest wall PTV

reduction

in

low‐dose

3

method described by Tyran et al.

spill

makes

the

is also shown in Fig. 3 for

and IM nodes and had been junctioned with the tangential photon

illustrative purposes. Differences in the penetration of the 5 Gy

ﬁeld, giving good sparing of the heart. For these speciﬁc patients,

isodose line into the ipsilateral lung can be seen between the plan-

the VMAT technique could not match the sparing of OARs from the

ning methods.

traditional 3DCRT‐based technique, although it generally did give

|
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better coverage. These were the only plans included in the study
that had the combination of left chest wall, IM nodes and a clinical
2.8

2.0a

4.1

3.2

1.1

plan that utilized electrons. Note that during the plan review, the
1.5

Contralateral
breast mean
dose (Gy)

BYRNE

ROs were told to assume that the dose distribution would be deliv-

8.9

utilized. Of the remaining two patients where the 3DCRT plan was
4.6a

7.7 (Lt), 4.6 (Rt)

ton‐electron junction like these, there is likely greater setup
uncertainty in the ﬁeld junction region than for the other techniques
12.4 (Lt)

8.6

2.4

5.3

Heart mean
dose (Gy)

ered to the patient as seen on screen, however for cases with a pho-

preferred by the majority, discussions with the ROs suggested that

was easy. Within the remaining group of plans, more trade‐offs were
seen, where the VMAT plan was not better in all areas. It was noted
23.0

24.1 (Lt), 5.4 (Rt)

both increased coverage and reduced OAR doses and the RO choice

19.5

15.0a

2.4

3.7

In the 10 plans where VMAT was unanimously preferred, VMAT

that one RO tended to prioritize improved coverage and reduced
maximum dose, while the other two prioritized improved OAR spar-

about the patients. An assumption of conﬁrmed positive nodes
would change the priority of the coverage of the nodes relative
to the OARs. In no cases was the 3DCRT plan unanimously the

3.4

2.9a

3.9 (Lt), 2.6 (Rt)

vague instructions given to the ROs about the assumptions to make

5.6 (Lt)

4.0

0.9

1.0

ing in these trade‐off areas. This is probably due to the somewhat

preferred option.
create the VMAT plans is that they were planned very much accord-

a

9534

5444

One of the limitations of the semiautomated method used to
6057

External
V5 Gy (cc)

Lung (Contralateral)
mean dose (Gy)

Lung (Contralateral)
V5 Gy (%)

in these cases both plans were considered almost equivalent.

ing to the clinical goals. In cases where the clinical goal was easily

Indicates that these data were used in single sample t test comparison to the present study.

50
10
Approx. 250° (single)
Lt breast + SC nodes

ideal level by the pseudo‐median VMAT plan (19/24) as compared to

a

Pasler et al.21

50
8
361°
Lt and Rt + all nodes
Johansen et al.6

50

50
19

12
360°

240° (dual)¹
Lt and Rt + various nodes

Lt and Rt + SC
nodes in 4 cases
Badakhshi et al.5

Boman et al.

4

50

50
10
240° (dual)
Lt + all nodes
Tyran et al.2

8

27
As described

As described
Lt + various nodes

Lt and Rt + various nodes

50

ularly be seen in how many of the clinical goals were passed at the

Present study

Plan method
Patient cohort
Study

cases further improvement being possible. This difference can partic-

Present study
(only Lt patients)

Prescription
(Gy)

met, the optimizer did not reduce the goal further despite in some

Number of
patients

Low‐dose metric

T A B L E 3 Comparison of common low‐dose metrics for a range of VMAT studies. Laterality indicated in brackets refers to the treatment plan. 1Bowan et al. report on several different arc
ranges but metrics for the 240° dual arc without arc splitting (NS240) are reported, as this arrangement was generally the best for contralateral lung and contralateral breast.
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the pseudo‐median 3DCRT plan (13/24). Of the ﬁve plan metrics
where there was a statistically signiﬁcant difference between the
plans and the 3DCRT plan was better, in four of them the VMAT
plan had already met the ideal goal and therefore was not working
to improve the plan in this area.
One of the advantages of using 40°–50° arcs for the breast/chest
wall is that the precise selection of gantry and collimator angles is
far less critical. The method of selecting nominal tangential gantry
angles did not always closely agree with the choice of tangential
gantry angles from the manual 3DCRT plan; however due to the use
of short arcs, these differences were partially compensated for in
the optimization process. It is noted that if the planning system
offered the option of directionally blocking parts of an arc to parts
of the PTV, it potentially would be possible to deliver the entire
VMAT beam arrangement described here in a single arc rotation.
The planning technique covers the junction region with both the
AX/SC arcs and the breast/chest wall tangential arcs. With this beam
arrangement, the optimizer automatically ensures that the dose is
feathered across this region, and that the plan is robust to small
interfraction movements. This occurs because the optimization algorithm starts the optimization with the ﬂuence set to the projection
of the target at each gantry angle, thus splitting ﬂuence between the
beams that cover the junction region.26 The ﬂuence is then modiﬁed
from this initial conﬁguration during the optimization process, but

BYRNE

|
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F I G . 3 . Comparison of typical dose distributions seen from multiple planning methods for a chest wall case with IM, SC and AX nodes. On
the left is the clinical 3DCRT plan, in the middle is the tangential VMAT plan, and on the right is a full arc VMAT plan. The lowest isodose line
displayed (purple) is 5 Gy to highlight the differences in the volume covered by this isodose.
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Dose (Gy)

40
VMAT Plan Dose
VMAT Breast/Chest wall arcs

30

VMAT AX/SC arcs
3DCRT Plan Dose
20

3DCRT Breast/Chest wall beams
3DCRT SC/AX beams

10

F I G . 4 . Dose contribution across
junction region between breast/chest wall
and AX/SC nodes from respective beams/
arcs for 3DCRT and VMAT plans for an
example case.
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Dose (Gy)
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VMAT 3mm Together
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3DCRT 3mm Together
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F I G . 5 . Dose change across junction
region with 3 mm longitudinal shift of SC/
AX beams relative to the breast/chest wall
beams for 3DCRT and VMAT plans for an
example case.
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0
0

2

4

6

8

10

Distance (cm)

always maintains some ﬂuence through each of the beams in this

of 2 cm in the superior‐inferior direction, but due to collimator

region, thus making the junction dose more gradual than the hard

angles could be larger in some areas. A representative example of

junction seen in 3DCRT plans. This overlap region was a minimum

the overlap region for one of the VMAT plans is shown in Fig. 4,
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displaying the gradual dose gradients. This line dose was taken at an

The results indicate that the VMAT technique described has the

oblique angle along the chest wall, hence the larger junction region

potential to result in improved dose distributions while taking recom-

seen. This example was recalculated with the AX/SC beams and arcs

mended precautions to account for patient movement. The usability

offset by 3 mm longitudinally, to simulate differential interfraction

results indicate that the VMAT technique may increase the average

motion. The expected dose variations in this scenario can be seen in

treatment time by approximately 1 min.

Fig. 5. While the VMAT has a larger region with dose variation, the
magnitude of the dose variation is signiﬁcantly reduced. Note that
Fig. 5 shows the dose distribution resulting if the whole treatment

5 | CONCLUSION

course was delivered with this differential motion, in practice these
differences average over numerous fractions.

Treatment planning of the breast/chest wall with nodes presents a

Although not explicitly tested in this study, the time taken to

very complex treatment planning situation. The results of this study

plan these patients using the semiautomated VMAT method is

indicate that while there are advantages and disadvantages to both

expected to be substantially quicker than the 3DCRT planning

3DCRT and VMAT treatment plans in this scenario, overall the

method. The automated plan creation component took approxi-

VMAT plans were generally better. The combination of tangential

mately 30 min to complete, which then required approximately 1 hr

VMAT arcs for the breast/chest wall with a larger arc for the AX and

of further optimization to result in a ﬁnished plan. This is longer than

SC nodes as described above maintains many of the advantages of

would normally be expected for RayStation optimization and is prob-

VMAT planning, while minimizing the volume receiving low doses,

ably due to the use of robust optimization, which can take up to

particularly on the contralateral side of the patient. In particular, this

three times longer per iteration.19 Note that this plan timing does

tangential VMAT method resulted in signiﬁcantly lower integral dose

not include the anatomy contouring step, which was not part of this

to the patient than the 3DCRT planning method. This planning pro-

study.

cedure can be carried out quickly and easily with a semiautomated

While all attempts were made to blind the RO from the planning

approach using scripting functions already available in the clinic.

method used during plan evaluation, the dose distributions differ sig-

Based on these results, the planning method utilized for any

niﬁcantly with characteristic shapes, making it possible for the RO to

given patient should be decided on a case by case basis, determined

determine the planning method based on the dose distribution alone.

by the patients treatment requirements and anatomy. However, the

It is acknowledged therefore that it is possible that the RO occasion-

availability of the VMAT technique described here is a useful

ally knew which plan they were selecting as the preferred option.
Another study limitation is that in practice PTV contouring can

addition to the treatment options available for this difﬁcult planning
situation.

vary according to the treatment planning method being used. As the
patients used in the study were contoured with the RO expecting
the treatment plan to be 3DCRT, in areas where coverage would
easily be achieved it is possible they implicitly assumed the coverage
would be adequate and paid less attention to PTV contouring in
these areas. However when these PTVs are used with a different
planning method, in this case VMAT, these implicit assumptions
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The results suggest that the VMAT planning method results in
superior plans for the majority of patients. The results also indicate
that for a small subset of patients; left chest wall patients where the
IM nodes require treatment and heart is close to the chest wall, this
planning method gives inferior results when compared to existing
planning methods. This planning scenario is particularly complex, and
neither plan for these patients was ideal. It is likely that the use of
DIBH in this scenario would substantially improve both plans and
may lead to more favorable results for the VMAT method, although
this may introduce other motion‐related considerations.
While it is often possible to get good dose distributions in the
planning system, how these translate into delivered dose distributions can vary, due to inter and intrafraction motion both near the
breast/chest wall ﬁeld junction, and on the patient external edge.
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